aspsirna0929 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0929
siRNA Name: MJD2
Gene:Ataxin-3 (ATXN3)
Disease:Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3)
Wild allele/target (5'->3'): GCAGCAGGGGGACCUAUCA
Mutant allele/target (5'->3'):GCAGCAGCGGGACCUAUCA
Target Mutation: c.209_211CAG(8_36),(p.Gln298_Gln305=)
Wild siRNA (As strand):CGUCGUCCCCCUGGAUAGU
ASP-siRNA (As strand):CGUCGUCGCCCUGGAUAGU
Mismatch position in siRNA: G12C
Mutant allele (5'->3'): GCAGCAGCGGGACCUAUCA
ASP-siRNA (As strand):CGUCGUCGCCCUGGAUAGU
ASP-siRNA efficacy for mutant allele:28
Wild allele (5'->3'): GCAGCAGGGGGACCUAUCA
ASP-siRNA (As strand):CGUCGUCGCCCUGGAUAGU
ASP-siRNA efficacy for wild allele:90
Percentage discrimination for ASP-siRNA:-62
Wild allele (5'->3'): GCAGCAGGGGGACCUAUCA
Wild siRNA (As strand):CGUCGUCCCCCUGGAUAGU
Wild sirna efficacy for wild allele:NA
Wild allele (5'->3'): GCAGCAGGGGGACCUAUCA
ASP-siRNA (As strand):CGUCGUCGCCCUGGAUAGU
Wild sirna efficacy for mutant allele:NA
Percentage discrimination for wild siRNA:NA
Concentration:10nM
Orientation:Double strand
Mismatch in:siRNA
UniProt ID: P54252
Target sequence: CAGCAGCAGCAGCAGCAGCAGGGGGACCUAUCAGGA
Genbank Accesion: NM_004993.5
Cell-line: 293T
Experimental technique used: Western blot
Transfection method: Lipofectamine Plus
siRNA expression method: Chemically synthesized
Post-transfection duration: 48 hours
OMID ID: 109150
KEGG disease ID:H00063
Reference:15236410

.
.
.
.
.
.
.
.
.
.
.

.

.

.